Delivery Order SPE2DB22D3301-SPE2DB25FY9AD
- Not listed
- The Defense Logistics Agency awarded a $25,655.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $225.73 to Amerisourcebergen Drug Corporation for the supply of 4561357537 units of 1 mg Anastrozole tablets. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle and calls for Amerisourcebergen to deliver the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, with performance required between June 27-28, 2023. As a leading provider of pharmaceuticals and...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,157.20 contract is for the delivery of 4,560,051,951 units of Anastrozole 1 mg tablets. The contract has an ultimate completion date of February 27, 2023 and was awarded on February 24, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
- The Defense Logistics Agency awarded a delivery order valued at $44,901.48 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $6,591.89 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.82 fixed-price contract is for the delivery of 90-count bottles of the generic drug Anastrozole 1 mg Tablets. The contract has a period of performance through March 28, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,616.17 by the Defense Logistics Agency on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by November 26, 2025. The award represents a continuation of AmerisourceBergen's...
- This federal contract award is a delivery order (SPE2DB24D2205|SPE2DB25FDXBZ) valued at $1,658.78, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Anastrozole 1 mg tablets in 90-count packages, a medication used in the treatment of breast cancer. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9ADDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Anastrozole 1 mg tablets (90-count) on August 7, 2025, with a ceiling value of $1,351.55 and completion date of August 8, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The delivery order for Anastrozole, a hormone therapy medication commonly used in cancer treatment, exemplifies the company's role in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains for federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/7/25 |